Maurizio Grilli

European life sciences real estate is increasingly recognised as a reliable source of long-term, secure income. Many top global managers are pursuing core strategies within this growing sector, underpinned by robust tenant demand and longer-than-average lease lengths. IPE Real Assets’ list of the top 150 real estate investment managers reveals that 40 out of 150 monitored managers are active in European life sciences real estate.

A standardised data collection form will be used for study characteristics and outcome data. Two review authors will independently extract all relevant data from the selected studies. The collected data will be shared and reviewed again. Any discrepancies will be discussed and consensus will be reached or a third independent author will be consulted. Data collection will be finished by May 2024.

Life sciences is a fast-growing economic sector, driven by multiple factors, including an ageing population and the increasing demand for advanced healthcare treatments and drugs. The term “life sciences” is very broad and is typically defined as the sciences concerned with the study of living organisms. It encompasses pharmaceuticals, medical devices and biotech.